tiprankstipranks
Trending News
More News >

Shanghai Pharmaceuticals Announces Change in H Share Registrar

Story Highlights
Shanghai Pharmaceuticals Announces Change in H Share Registrar

Don’t Miss TipRanks’ Half-Year Sale

Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has provided an update.

Shanghai Pharmaceuticals Holding Co., Ltd. announced a change in its H Share Registrar in Hong Kong, effective from 1 August 2025. This change to Tricor Investor Services Limited is expected to streamline the registration and transfer process for stakeholders, potentially impacting the company’s operational efficiency and investor relations.

The most recent analyst rating on (HK:2607) stock is a Buy with a HK$15.70 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.

More about Shanghai Pharmaceuticals Holding Co

Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company is involved in the manufacturing and distribution of pharmaceutical products and services, focusing on the Chinese market.

Average Trading Volume: 6,974,128

Technical Sentiment Signal: Hold

Current Market Cap: HK$65.32B

For detailed information about 2607 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1